| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/18/1994 | WO1994017823A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
| 08/18/1994 | WO1994017813A1 Defective sindbis virus vectors that express toxoplasma gondii p30 antigens |
| 08/18/1994 | WO1994017812A1 Immune system modulation using psoralens activated with visible light |
| 08/18/1994 | WO1994017810A1 Recombinant cytomegalovirus vaccine |
| 08/18/1994 | WO1994017773A2 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/18/1994 | WO1994010203A3 Op-3-induced morphogenesis |
| 08/18/1994 | CA2156084A1 A pharmaceutical preparation for topical administration of antigens and/or vaccines to mammals via a mucosal membrane |
| 08/18/1994 | CA2155725A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | CA2155646A1 Phospho-specific antibodies against a creb derived peptide |
| 08/18/1994 | CA2155645A1 Nuclear matrix proteins |
| 08/18/1994 | CA2155545A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | CA2155413A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | CA2155109A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | CA2155103A1 Tnf-alpha muteins and a process for preparing them |
| 08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | CA2153794A1 Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
| 08/18/1994 | CA2117889A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/17/1994 | EP0610447A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
| 08/17/1994 | EP0610436A1 Hepatitis-c virus testing |
| 08/17/1994 | EP0610427A1 TGF-$g(b) TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 08/17/1994 | EP0610345A1 Combined cellular and immunosuppressive therapies |
| 08/17/1994 | EP0610335A1 Recombitope peptides |
| 08/17/1994 | EP0610322A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 08/17/1994 | EP0610320A1 Purified chitin deacetylase |
| 08/17/1994 | EP0610298A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 08/17/1994 | EP0610290A1 Treatment of ocular inflammation by blockage of cell adhesion molecules |
| 08/17/1994 | EP0610286A1 Recombinant immunotoxins |
| 08/17/1994 | EP0610260A1 Vaccines for actinobacillus pleuropneumoniae |
| 08/17/1994 | EP0610257A1 In vitro antibody perfusion of kidney grafts |
| 08/17/1994 | EP0610254A1 Glial derived neurotrophic factor |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | CN1090929A Immunoassay for isothiazolones |
| 08/16/1994 | US5338850 Pyridinium derivatives |
| 08/16/1994 | US5338836 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 08/16/1994 | US5338832 Antigen recognized by MCA 16-88 |
| 08/16/1994 | US5338829 Peptides derived from human immunodeficiency virus-1 GP160 |
| 08/16/1994 | US5338683 Genetic engineering, vaccines |
| 08/16/1994 | US5338674 Process for producing a vaccine for a pathogenic RNA virus and product thereof |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/16/1994 | US5338543 Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
| 08/16/1994 | CA1331445C Vaccine against e. coli septicaemia in poultry |
| 08/16/1994 | CA1331444C Ibdv production in continuous lines |
| 08/16/1994 | CA1331443C Saponin adjuvant |
| 08/11/1994 | DE4310516A1 Lipoprotein (a) peptides and their use |
| 08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| 08/10/1994 | EP0609739A1 Method of reversing immunosuppression in vaccines |
| 08/10/1994 | EP0609722A1 An in vitro method for detecting the presence of invasive stimuli in mammals |
| 08/10/1994 | EP0609580A1 Recombinant CMV neutralising proteins |
| 08/10/1994 | EP0609393A1 VIRULENCE ASSOCIATED PROTEINS IN $i(BORRELIA BURGDORFERI (Bb)) |
| 08/10/1994 | EP0609305A1 Type c-like human retrovirus linked to multiple sclerosis (ms) |
| 08/10/1994 | EP0436620B1 Matrix with immunomodulating activity |
| 08/10/1994 | EP0428656B1 Human cell line lc5 and its use |
| 08/10/1994 | CN1090584A Synthetic polypeptides |
| 08/09/1994 | US5336760 Method and useful apparatus for preparing pharmaceutical compositions |
| 08/09/1994 | US5336758 AIDS vaccines |
| 08/09/1994 | US5336742 Polymeric supports |
| 08/09/1994 | US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae |
| 08/09/1994 | US5336618 Monoclonal antibody of the class IgG1, designated 7E3, reacts readily with both normal human and dog blood platelets while fail to react with thrombasthenic human platelets |
| 08/09/1994 | US5336616 Method for processing and preserving collagen-based tissues for transplantation |
| 08/09/1994 | US5336491 Using Pasteurella haemolytica antigen |
| 08/09/1994 | US5336490 Haemophilus influenzae pilus vaccines |
| 08/09/1994 | CA1331355C Immunopotentation |
| 08/09/1994 | CA1331339C Stabilizing vaccines |
| 08/06/1994 | WO1994017820A1 Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same |
| 08/06/1994 | CA2126455A1 Liver fluke vaccine and polypeptides useful for same |
| 08/04/1994 | WO1994017415A1 Novel anticoagulant cofactor activity |
| 08/04/1994 | WO1994017411A1 Methods and agents for the diagnosis and treatment of rheumatoid arthritis |
| 08/04/1994 | WO1994017196A1 Detection and treatment of mutations in a cd40 ligand gene |
| 08/04/1994 | WO1994017192A2 Lysosomal targeting of immunogens |
| 08/04/1994 | WO1994017187A1 CLONING AND EXPRESSION OF PLASMODIUM FALCIPARUM TRANSMISSION-BLOCKING TARGET ANTIGEN, Pfs230 |
| 08/04/1994 | WO1994017104A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | WO1994017103A1 Streptococcus suis adhesin protein and method for producing it |
| 08/04/1994 | WO1994017100A1 Icam-related protein |
| 08/04/1994 | WO1994017087A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | WO1994016741A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | WO1994016737A1 Compositions and methods for delivery of genetic material |
| 08/04/1994 | WO1994016735A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/04/1994 | WO1994016731A1 Ganglioside-klh conjugate vaccines with qs-21 |
| 08/04/1994 | WO1994016730A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | WO1994016728A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants |
| 08/04/1994 | WO1994016727A1 Immunotherapeutic composition |
| 08/04/1994 | WO1994016725A1 Live coccidiosis vaccine |
| 08/04/1994 | WO1994016724A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | WO1994016716A1 Recombinant virus immunotherapy |
| 08/04/1994 | WO1994016713A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | WO1994016684A1 INHIBITION OF βARK AND β-ARRESTIN |
| 08/04/1994 | WO1994016681A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | WO1994013808A3 LYMPHOTOXIN-β, LYMPHOTOXIN-β COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF |
| 08/04/1994 | WO1994005700A3 Methods and reagents to detect and characterize norwalk and related viruses |
| 08/04/1994 | WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof |
| 08/04/1994 | CA2154902A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | CA2154896A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | CA2154882A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | CA2154487A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | CA2154468A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | CA2154346A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | CA2154278A1 Anti-lfa-1 monoclonal antibodies used for the preparation of a medecine prenventing the rejection of grafted organs |
| 08/04/1994 | CA2153790A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | CA2132637A1 Icam-related protein |